Approvals (Drugs@FDA)

KERENDIA

BAYER HLTHCARE · FINERENONE

NDA215341Drug (NDA)Prescription
Open FDA's page for this record
Application number
NDA215341
Sponsor name
BAYER HLTHCARE
Submissions
  1. Submission type
    SUPPL
    Submission number
    1
    Submission status
    AP
    Submission status date
    20220901
    Review priority
    STANDARD
    Submission class code
    EFFICACY
    Submission class code description
    Efficacy
    Application docs
    1. ID
      71995
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/215341Orig1s001ltr.pdf
      Date
      20220902
      Type
      Letter
    2. ID
      72002
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215341s001lbl.pdf
      Date
      20220902
      Type
      Label
  2. Submission type
    SUPPL
    Submission number
    11
    Submission status
    AP
    Submission status date
    20260916
    Review priority
    PRIORITY
    Submission class code
    EFFICACY
    Submission class code description
    Efficacy
    Application docs
    1. ID
      87213
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/215341Orig1s011ltr.pdf
      Date
      20260921
      Type
      Letter
    2. ID
      87232
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215341s011lbl.pdf
      Date
      20260922
      Type
      Label
  3. Submission type
    SUPPL
    Submission number
    9
    Submission status
    AP
    Submission status date
    20250711
    Review priority
    PRIORITY
    Submission class code
    EFFICACY
    Submission class code description
    Efficacy
    Application docs
    1. ID
      82856
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215341Orig1s009lbl.pdf
      Date
      20260512
      Type
      Label
    2. ID
      82867
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/215341Orig1s009ltr.pdf
      Date
      20250715
      Type
      Letter
  4. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20210709
    Review priority
    PRIORITY
    Submission class code
    TYPE 1
    Submission class code description
    Type 1 - New Molecular Entity
    Application docs
    1. ID
      68045
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215341s000lbl.pdf
      Date
      20210712
      Type
      Label
    2. ID
      68048
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/215341Orig1s000ltr.pdf
      Date
      20210712
      Type
      Letter
    3. ID
      68296
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/215341Orig1s000TOC.html
      Date
      20210805
      Type
      Review
Products
  1. Product number
    002
    Reference drug
    Yes
    Brand name
    KERENDIA
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      FINERENONE
      Strength
      20MG
  2. Product number
    003
    Reference drug
    Yes
    Brand name
    KERENDIA
    Reference standard
    Yes
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      FINERENONE
      Strength
      40MG
  3. Product number
    001
    Reference drug
    Yes
    Brand name
    KERENDIA
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      FINERENONE
      Strength
      10MG
Harmonized identifiers (openFDA)
Application number
NDA215341
Brand name
KERENDIA
Generic name
FINERENONE
Manufacturer name
Bayer HealthCare Pharmaceuticals Inc.
Product NDC
50419-540, 50419-541, 50419-542
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
FINERENONE
RxCUI
2562816, 2562822, 2562824, 2562826, 2720069, 2720071
SPL ID
0be3a1c5-0088-43b1-b2f0-1faa1ea87c5b
SPL set ID
fc726765-5d5a-4d6e-b037-b847bda9fb7c
Package NDC
50419-540-01, 50419-540-02, 50419-540-70, 50419-540-06, 50419-541-01, 50419-541-02, 50419-541-70, 50419-541-06, 50419-542-01, 50419-542-02, 50419-542-70, 50419-542-06
Nui
N0000193970, N0000000139
Pharm class epc
Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]
Pharm class moa
Mineralocorticoid Receptor Antagonists [MoA]
UNII
DE2O63YV8R
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.